Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide caused damage to male rat reproductive organs and may affect fertility.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Hormones significantly affect skin health, with vitamin D playing a key role.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Women's acne improvement with antibiotics is not linked to signs of high male hormones.

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Two treatments for male pattern hair loss are minoxidil and finasteride, but they have side effects and may not satisfy everyone.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Hyperthyroidism can hide signs of high androgen levels in females.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Blocking testosterone speeds up wound healing in males.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Spironolactone reduced hair thickness and some testosterone levels in women with excessive hair growth.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

No cure for female pattern hair loss, but various effective treatments exist.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.